ShutterWorx/iStock via Getty Images
Spending on cancer drugs is expected to reach $441B globally in 2029 despite a slowdown later in the decade as key oncology medicines lose market exclusivity, drug analytics and contract research firm IQVIA (IQV) said in a recent report.
In